BEAT Therapeutics
Porto Carreiro
About BEAT Therapeutics
BEAT Therapeutics develops first-in-class targeted therapies for cancer treatment. The company focuses on disrupting cancer's survival mechanisms at the DNA repair level. This approach exploits genomic instability as a selective vulnerability to improve treatment efficacy and minimize side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: beattherapeutics.com
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/beat-therapeutics-2647283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.